Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 862, pseudogene (RN7SL862P) is a **pseudogene**—a nonfunctional genomic sequence similar to the gene encoding 7SL RNA, which is part of the signal recognition particle (SRP) ribonucleoprotein complex responsible for targeting specific proteins to the endoplasmic reticulum during translation[1][9]. However, as a pseudogene, RN7SL862P does not produce a functional RNA or protein product and lacks known biological activity. The human genome contains hundreds of 7SL RNA–derived pseudogenes, most of which are truncated and generated by integration of reverse-transcribed RNA copies back into the genome[5][7][10]. Pseudogenes like RN7SL862P are generally not considered therapeutic targets, but their transcripts can in rare cases act as regulatory RNAs; current evidence does not support any clinical or functional significance for RN7SL862P itself[6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 862, pseudogene (RN7SL862P).